INTERWEST VENTURE MANAGEMENT CO - Q1 2020 holdings

$94.7 Million is the total value of INTERWEST VENTURE MANAGEMENT CO's 12 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 0.0% .

 Value Shares↓ Weighting
REAL SellTHE REALREAL$36,130,000
-71.4%
5,154,080
-23.1%
38.16%
-29.9%
GKOS  GLAUKOS CORP$31,272,000
-43.3%
1,013,3640.0%33.03%
+38.8%
MGNX  MACROGENICS INC$6,253,000
-46.5%
1,074,3160.0%6.60%
+31.1%
EIGR  EIGER BIOPHARMACEUTICALS INC$5,201,000
-54.4%
764,9180.0%5.49%
+11.8%
AGTC  APPLIED GENETIC TECHNOL CORP$4,776,000
-27.4%
1,455,9040.0%5.04%
+77.8%
CDTX  CIDARA THERAPEUTICS INC$3,365,000
-35.4%
1,356,8130.0%3.56%
+58.3%
KALV  KALVISTA PHARMACEUTICALS INC$2,974,000
-57.0%
388,7660.0%3.14%
+5.3%
VERO  VENUS CONCEPT INC$2,338,000
-24.5%
658,6570.0%2.47%
+85.0%
STIM  NEURONETICS INC$1,948,000
-57.9%
1,030,6890.0%2.06%
+3.2%
 OBALON THERAPEUTICS INC$274,000
-62.0%
380,2240.0%0.29%
-7.1%
XENE  XENON PHARMACEUTICALS INC$94,000
-13.8%
8,2930.0%0.10%
+110.6%
DARE  DARE BIOSCIENCE INC$43,000
+4.9%
50,3680.0%0.04%
+150.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-04-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GLAUKOS CORP28Q3 202333.0%
EIGER BIOPHARMACEUTICALS INC24Q3 202217.7%
APPLIED GENETIC TECHNOL CORP24Q3 20226.7%
XENON PHARMACEUTICALS INC20Q3 20210.6%
CIDARA THERAPEUTICS INC19Q2 20214.5%
THE REALREAL18Q3 202362.6%
KALVISTA PHARMACEUTICALS INC17Q4 202010.8%
DARE BIOSCIENCE INC16Q3 20230.3%
MACROGENICS INC14Q1 202019.2%
PMV PHARMACEUTICALS INC13Q3 202367.5%

View INTERWEST VENTURE MANAGEMENT CO's complete holdings history.

Latest filings
TypeFiled
1442024-02-27
13F-HR2023-10-20
13F-HR2023-07-21
13F-HR2023-04-27
13F-HR2023-01-31
13F-HR2022-10-25
13F-HR2022-08-02
13F-HR2022-04-13
13F-HR2022-01-25
13F-HR2021-10-19

View INTERWEST VENTURE MANAGEMENT CO's complete filings history.

Compare quarters

Export INTERWEST VENTURE MANAGEMENT CO's holdings